DALLAS, Texas, August 17, 2011 /PRNewswire/ --
The "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)" analyzes the biochip market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for biochip market in North America, Europe, Asia, and Rest of the World.
Browse market data tables and in-depth TOC on "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)".
Early buyers will receive 10% customization on reports.
Biochips were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence seen an influx of players vying fiercely for a share of this market. The global biochips market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 Billion by 2015; growing at a CAGR of 16.7%.Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), Luminex Corporation (U.S.), Bio-Rad Laboratories (U.S.), Biacore Life Sciences by GE Healthcare (Sweden), EMD Millipore (U.S.), Life Technologies (U.S.), Perkin Elmer (U.S.), Caliper Life Sciences (U.S.), Fluidigm Corporation (U.S.), Cepheid (U.S.), Epoch Biosciences (U.S.), US Bioma
Copyright©2010 PR Newswire.
All rights reserved